[Trial of device that is not approved or cleared by the U.S. FDA]
Withheld · NCT07014995
At a glance
- Research payments reported, 2025
- $50,040
- U.S. investigators named
- 5
- Sites paid
- 5
About the trial
- Sponsor
- [Redacted]
- Results posted
- Not yet
From ClinicalTrials.gov, last updated 2025-08-05. Full record, eligibility and contacts (opens in a new tab)
Industry funding
AbbVie Inc. reported $50,040 in research payments for this study in 2025 (5 payments).
Research payments usually go to hospitals, universities and research sites to run a study, not to the investigators personally. A payment is not evidence of wrongdoing.
U.S. investigators named on this study
- Melanie D. Palm, M.D. Dermatology · Solana Beach, CA
- Cheryl M. Burgess, M.D. Dermatology · Washington, DC
- Joely Kaufman-janette, MD Dermatology · Coral Gables, FL
- Kavita Mariwalla, M.D Mohs Surgery · West Islip, NY
- Jose R. Montes, MD Ophthalmology · San Juan, PR
Clinicians the company named as principal investigators in its Open Payments reports.
Sites paid to run it
- Center for Dermatology and Dermatologic Surgery Management LLC $10,702
- Skin Research Institute LLC $9,834
- Jose Raul Montes Eyes & Facial Rejuvenation $9,834
- Art of Skin MD $9,834
- Mariwalla Dermatology $9,834
Sources: CMS Open Payments research payments (program year 2025) and ClinicalTrials.gov, U.S. National Library of Medicine.